Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today. Worldwide revenue was $15.56 billion, up 38% from the same period a year ago. GAAP net income increased 91% to $5.6 billion, or $6.29 per share, compared to last year. Adjusted EPS rose 61% to $6.31. The company raised its full-year […]
“Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today. Worldwide revenue was $15.56 billion, up 38% from the same period a year ago. GAAP net income increased 91% to $5.6 billion, or $6.29 per share, compared to last year. Adjusted EPS rose 61% to $6.31. The company raised its full-year […]
· August 7, 2025
Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today.
Worldwide revenue was $15.56 billion, up 38% from the same period a year ago.
GAAP net income increased 91% to $5.6 billion, or $6.29 per share, compared to last year. Adjusted EPS rose 61% to $6.31.
The company raised its full-year 2025 guidance based on strong business performance. Revenue is now expected to be $60-62 billion. GAAP EPS is now expected to be $20.85-22.10 while adjusted EPS is expected to be $21.75-23.00.
